Advanced · Licensed prescribers: MD/DO
Advanced Clinical Peptide Therapeutics
Advanced clinical education for prescribing practitioners
Post-graduate peptide therapeutics program for licensed prescribers: pharmacology, evidence-based protocols, condition-specific frameworks and US medico-legal governance. Five modules, 62 assessed questions.
- Clinical modules
- 5
- Clinical modules
- Assessed questions
- 62
- Assessed questions
- Clinical slides
- 80+
- Clinical slides
- References
- 40+
- References
$150
One-time payment · lifetime access
What's included
- Five structured clinical modules across all major peptide classes
- 80+ clinical slides with mechanism diagrams and lab tables
- 62 graded assessment questions with rationale
- Mandatory pre-treatment laboratory framework
- US medico-legal governance — consent, documentation, DEA tiers
- Condition-specific decision frameworks for six presentations
- 40+ peer-reviewed references
- Lifetime access — one-time payment
A comprehensive post-graduate clinical reference
Pharmacology, evidence-based prescribing protocols, condition-specific frameworks and medico-legal governance — structured as five CME-formatted modules with 62 assessed questions and a certificate on successful completion.
Prerequisite strongly recommended: complete Peptide Fundamentals first. This course assumes familiarity with peptide classes, mechanisms, the Fast-Fail safety matrix, dosing frameworks and contraindications.
Learning objectives
Module I — Regulatory mastery & prescribing authority. Advanced peptide biochemistry (PEGylation, lipidation, D-amino acid substitution, cyclisation). The FDA four-tier framework: approved, off-label, compounded 503A/503B and investigational. State-level prescribing authority for MD, DO, NP and PA across telemedicine and in-clinic settings, including Ryan Haight Act compliance.
Module II — Mechanism-based pharmacology & PK/PD. Receptor-level pharmacodynamics across GLP-1/GIP, GH-axis, mitochondrial, repair and immune peptide classes, and the mandatory pre-treatment laboratory framework with threshold-based action criteria.
Module III — Evidence-based prescribing protocols. Titration frameworks, monitoring schedules, stacking interaction rules, contraindications and the two-failure threshold as a clinical governance standard.
Module IV — Condition-specific clinical frameworks. Obesity and metabolic disease, male hypogonadism and fertility, musculoskeletal injury and wound healing, immune dysregulation, sexual medicine and Long COVID/PEM — plus WADA/USADA considerations for athletes.
Module V — Safety, medico-legal & clinical governance. Informed consent, MedWatch adverse event reporting, DEA scheduling, state board documentation, 503A prescription elements and risk-stratified practice governance.
Assessment
| Module | Questions | Pass mark |
|---|---|---|
| I — Science & Regulatory | 8 | 6 / 8 |
| II — Clinical Pharmacology | 14 | 10 / 14 |
| III — Prescribing Protocols | 10 | 7 / 10 |
| IV — Condition-Specific Use | 20 | 14 / 20 |
| V — Safety & Medico-Legal | 10 | 7 / 10 |
| Total | 62 | ≥ 70% |
Grades: Distinction 90–100% · Merit 80–89% · Pass 70–79%. Reassessment is available after module review.
Who should enrol
Physicians (MD/DO), nurse practitioners, physician assistants, clinical pharmacists, sports & exercise medicine specialists, longevity and integrative medicine physicians, endocrinologists and telehealth prescribers. This course is designed for licensed practitioners and is not suitable for patients.
Curriculum
7 sections · 13 lessons · approx. 5 hours
Introduction2 lessons
- Welcome & how to use this courseFree preview
- Legal & medical disclaimerFree preview
Module I — Science & Regulatory Framework2 lessons
- Science & Regulatory Framework
- Module I assessment
Module II — Clinical Pharmacology2 lessons
- Clinical Pharmacology
- Module II assessment
Module III — Clinical Prescribing Protocols2 lessons
- Clinical Prescribing Protocols
- Module III assessment
Module IV — Condition-Specific Clinical Protocols2 lessons
- Condition-Specific Clinical Protocols
- Module IV assessment
Module V — Safety, Medico-Legal & Clinical Governance2 lessons
- Safety, Medico-Legal & Clinical Governance
- Module V assessment
Conclusion and Final Words1 lesson
- Conclusion and final words
Your instructor
Dr Sean Hall, MD, PhD, MBA
- Medical doctor and research physician with 20+ years in chronic illness, translational medicine and emerging therapeutics.
- Specialist focus on peptide science, human microbiome research and evidence-based clinical application.
- Active researcher (h-index 16, 35+ peer-reviewed papers) and inventor on 47 patents globally.
- Former Chairman and CEO across public and private healthcare enterprises in the US, Europe and Australia.
- Research-based practice only: does not see patients outside approved clinical trial settings.
Frequently asked questions
Do I need to take Peptide Fundamentals first?
It is strongly recommended. The advanced course assumes familiarity with receptor classes, dosing principles, stacking rules and the Fast-Fail safety matrix.
Is this course for patients?
No. It is designed exclusively for licensed healthcare practitioners working within their scope of practice.
How is the course assessed?
62 questions across five modules. A score of 70% or higher per module and overall is required for the certificate, with Merit and Distinction grades for higher scores.
Which jurisdiction does the medico-legal content cover?
The regulatory and medico-legal content is built around US federal and state frameworks (FDA, DEA, 503A/503B, state boards).
For educational purposes only. Designed for licensed healthcare practitioners operating within their scope of practice. Does not recommend or promote any brand or provide a method to purchase peptides. Several peptides discussed are not approved for human therapeutic use.
$150
Lifetime access
Questions before enrolling? Contact Dr Hall.